Johnny Powers
Direktor/Vorstandsmitglied bei ZOMEDICA CORP.
Vermögen: 289 250 $ am 30.04.2024
Profil
Johnny D.
Powers is the founder of Jd Powers Consulting Group.
He is currently an Independent Director at Zomedica Corp.
He has formerly worked as a Director at Organon Teknika Corp.
LLC, Vice President-Cancer Diagnostics business at Becton, Dickinson & Co., Executive Vice President at IDEXX Laboratories, Inc., Vice President & GM-Manufacturing Operations at Ventana Medical Systems, Inc., and President at TriPath Oncology, Inc. He has an undergraduate degree from Wake Forest University, a graduate degree from Clemson University, a doctorate from North Carolina State University, and an MBA from The Fuqua School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZOMEDICA CORP
0,23% | 17.05.2024 | 2 225 000 ( 0,23% ) | 289 250 $ | 30.04.2024 |
Aktive Positionen von Johnny Powers
| Unternehmen | Position | Beginn |
|---|---|---|
| ZOMEDICA CORP. | Direktor/Vorstandsmitglied | 16.08.2019 |
| Jd Powers Consulting Group | Gründer | - |
Ehemalige bekannte Positionen von Johnny Powers
| Unternehmen | Position | Ende |
|---|---|---|
| IDEXX LABORATORIES, INC. | Corporate Officer/Principal | 08.02.2016 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01.01.2008 |
TriPath Oncology, Inc.
 TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Präsident | 01.01.2007 |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | 01.01.2001 |
Organon Teknika Corp. LLC
 Organon Teknika Corp. LLC Financial ConglomeratesFinance Part of Merck & Co., Inc., Organon Teknika Corp. LLC is an American company led by the management of PerImmune. | Direktor/Vorstandsmitglied | 01.01.1996 |
Ausbildung von Johnny Powers
| Wake Forest University | Undergraduate Degree |
| Clemson University | Graduate Degree |
| North Carolina State University | Doctorate Degree |
| The Fuqua School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| IDEXX LABORATORIES, INC. | Health Technology |
| ZOMEDICA CORP. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Commercial Services |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Organon Teknika Corp. LLC
Organon Teknika Corp. LLC Financial ConglomeratesFinance Part of Merck & Co., Inc., Organon Teknika Corp. LLC is an American company led by the management of PerImmune. | Finance |
| Jd Powers Consulting Group |